In partial fulfillment of the requirements for the Doctor of Philosophy degree in the Graduate School of Biomedical Sciences, Rebecca Johnson will present a seminar entitled, “SR-B1 Directed Nanoparticles as a Drug Delivery System against Triple Negative Breast Cancer,” on November 19, 2015, at 10:00 a.m. in EAD-506. The campus community is invited to attend. A private defense with the advisory committee will immediately follow the seminar.
Ms. Johnson is a doctoral student in Biochemistry and Cancer Biology, under the supervision of Andras Lacko, Ph.D., Institute for Cardiovascular and Metabolic Disease.